|
End-of-day quote
LUXEMBOURG S.E.
2026-09-21
|
5-day change | 1st Jan Change | ||
| 14.50 USD | +1.40% |
|
+1.40% | -13.69% |
| 09-03 | India's Cipla, China's Qilu partner for US launch of Merck's Keytruda biosimilar | RE |
| 08-25 | Cipla's Pithampur, India Unit Gets 7 Observations From US FDA | MT |
| Market Cap | 1,120B 11.69B 10.19B 9.6B 8.74B 16.39B 16.41B 115B 44.3B 570B 43.9B 42.93B 1,841B | P/E 2027 * |
27x | P/E 2028 * | 21.7x |
|---|---|---|---|---|---|
| Enterprise Value | 1,014B 10.58B 9.23B 8.69B 7.91B 14.84B 14.85B 104B 40.11B 516B 39.75B 38.87B 1,666B | EV / Sales 2027 * |
3.27x | EV / Sales 2028 * | 2.85x |
| Free-Float |
68.87% | Yield 2027 * |
0.94% | Yield 2028 * | 1.06% |
Last Transcript: Cipla Limited
| 1 day | +1.40% | ||
| 1 week | +1.40% | ||
| Current month | -2.68% | ||
| 1 month | -2.68% | ||
| 3 months | +0.69% | ||
| 6 months | +7.41% | ||
| Current year | -13.69% |
| 1 week | 14.2 |  | 14.5 |
| 1 month | 14.2 | | 15 |
| Current year | 12.8 | | 17 |
| 1 year | 12.8 | | 18.9 |
| 3 years | 12.8 | | 20 |
| 5 years | 10.4 | | 20 |
| 10 years | 4.94 | | 20 |
| Manager | Title | Age | Since |
|---|---|---|---|
Achin Gupta
CEO | Chief Executive Officer | - | 2026-03-31 |
Dinesh Jain
DFI | Director of Finance/CFO | - | 2026-07-23 |
Sushrut Kulkarni
PSD | President | - | 2026-05-17 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 90 | 1972-07-20 | |
| Director/Board Member | 72 | 2014-07-24 | |
| Director/Board Member | 71 | 2021-06-29 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.40% | +1.40% | - | - | 11.69B | |
| -0.54% | +1.27% | +13.04% | +64.11% | 46.81B | |
| -1.02% | -1.29% | +36.59% | +104.00% | 37.1B | |
| +1.02% | +6.69% | +13.21% | +96.86% | 12.09B | |
| -1.22% | +1.34% | -11.22% | +15.45% | 11.69B | |
| 0.00% | -0.95% | +19.27% | +142.99% | 9.03B | |
| +0.55% | +2.71% | +31.77% | +42.86% | 7.45B | |
| -0.00% | +3.34% | +21.47% | +205.31% | 7.22B | |
| -0.06% | +2.20% | +39.67% | -16.79% | 7.13B | |
| +3.26% | +3.77% | -40.07% | +13.57% | 5.19B | |
| Average | +0.34% | +1.99% | +13.75% | +74.26% | 15.97B | |
| Weighted average by Cap. | -0.19% | +1.03% | +18.35% | +78.31% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 310B 3.23B 2.82B 2.66B 2.42B 4.54B 4.54B 31.81B 12.26B 158B 12.15B 11.88B 509B | 347B 3.63B 3.16B 2.98B 2.71B 5.08B 5.09B 35.66B 13.74B 177B 13.62B 13.32B 571B |
| Net income | 41.35B 432M 376M 354M 323M 605M 606M 4.25B 1.64B 21.07B 1.62B 1.59B 67.98B | 51.42B 537M 468M 441M 401M 753M 754M 5.28B 2.03B 26.2B 2.02B 1.97B 84.53B |
| Net Debt | -106B -1.11B -965M -909M -828M -1.55B -1.55B -10.89B -4.2B -54.03B -4.16B -4.07B -174B | -131B -1.37B -1.2B -1.13B -1.03B -1.92B -1.93B -13.49B -5.2B -66.96B -5.15B -5.04B -216B |
| Date | Price | Change |
|---|---|---|
| 26-09-21 | US$14.50 | +1.40% |
| 26-09-18 | US$14.30 | 0.00% |
| 26-09-17 | US$14.30 | +0.70% |
| 26-09-16 | US$14.20 | 0.00% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CIPLA Stock
- CIPLA Stock
Select your edition
All financial news and data tailored to specific country editions
